Tricida, Inc. is a pharmaceutical company focused on the development and commercialization of a novel treatment for patients with chronic kidney disease.
Founded in 2013, Tricida is led by a seasoned management team that has extensive experience in the development and commercialization of therapeutics, with deep expertise in developing polymers for the treatment of kidney-related diseases